People · Operator
Named in public records as an officer, director or promoter · active 2006–2026 · Healthtech, Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Imperative Care, Inc. | — | Healthtech | Series D+ | $584.7M | $712.6M | 2016 |
| Instylla, Inc. | — | Biotechnology | Series B | $85.5M | $100.2M | 2017 |
| Ocular Therapeutix, Inc | — | Biotechnology | Series B | $81.0M | $1.5B | 2006 |
| Rejoni, Inc. | — | Biotechnology | Series B | $41.0M | $363.7M | 2020 |
| Augmenix Inc | — | Biotechnology | Series A | $40.6M | $216.9M | 2008 |
| Access Closure, Inc. | — | Other | Series A | $23.6M | $15.6M | 2008 |
| Sadra Medical, Inc. | — | Other Health Care | Series B | $23.0M | $88.6M | 2009 |
| Hotspur Technologies Inc | — | Other Health Care | Seed | $20.6M | $91.2M | 2009 |
| Squareone, Inc. | — | Other Health Care | Series A | $15.9M | $81.5M | 2009 |
| Tulavi Therapeutics, Inc. | — | Biotechnology | Series A | $14.5M | $17.9M | 2018 |
| Apama Medical, Inc. | — | Healthtech | Series A | $14.3M | $297.4M | 2009 |
| Ostial Corp | — | Other Health Care | Series A | $10.4M | $71.6M | 2019 |
| Maya Medical, Inc. | — | Other Health Care | Seed | $6.9M | $25.8M | 2010 |
| Truvic Medical, Inc. | — | Healthtech | Series A | $5.9M | $132.9M | 2020 |
FARHAD KHOSRAVI at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside FARHAD KHOSRAVI on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tara Butler | 5 | 12 |
| Amar Sawhney | 5 | 6 |
| Amarpreet Sawhney | 4 | 8 |
| Henry Chen | 4 | 7 |
| Steven Cagnetta | 3 | 5 |
| Rob Kuhling | 3 | 3 |
| Mark Wan | 2 | 10 |
| AMR SALAHIEH | 2 | 10 |
| Jeffrey Lightcap | 2 | 5 |
| Hank Plain | 2 | 5 |
| Daniel Davis | 2 | 4 |
| Greg Casciaro | 2 | 4 |
| Patrick Campbell | 2 | 4 |
| Jon Bohane | 2 | 3 |
| Tasneem Dohadwala | 2 | 2 |
| Louis Soto | 2 | 2 |
| MOTASIM SIRHAN | 2 | 2 |
| David Martin | 1 | 13 |
| Richard Lindstrom | 1 | 13 |
| Alan Crane | 1 | 9 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.